Evidence map›Paper›PMID 33127964›Full record

ArticleScientific reports2020

Preparation and characterization of amnion hydrogel and its synergistic effect with adipose derived stem cells towards IL1β activated chondrocytes.

Maumita Bhattacharjee, Jorge L Escobar Ivirico, Ho-Man Kan, Rosalie Bordett, Rishikesh Pandey, Takayoshi Otsuka, Lakshmi S Nair, Cato T Laurencin

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Classes of Stem Cells: From Biology to Engineering.Regenerative engineering and translational medicine · 2024
    Article
  13. Review
  14. Development of porcine skeletal muscle extracellular matrix-derived hydrogels with improved properties and low immunogenicity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Biological Scaffolds for Congenital Heart Disease.Bioengineering (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maumita BhattacharjeeConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Jorge L Escobar IviricoRaymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences, University of Connecticut Health, Farmington, CT, USA.
Ho-Man KanConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Rosalie BordettConnecticut Children's Innovation Center, School of Medicine, University of Connecticut Health, Farmington, CT, USA.
Rishikesh PandeyConnecticut Children's Innovation Center, School of Medicine, University of Connecticut Health, Farmington, CT, USA.
Takayoshi OtsukaConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Lakshmi S NairConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA.
Cato T LaurencinConnecticut Convergence Institute for Translation in Regenerative Engineering, University of Connecticut Health, 263 Farmington Ave, Farmington, CT, 06030, USA. Laurencin@uchc.edu.
UConn Health · USConnecticut Children's Medical Center · US

Funding

Regenerative Engineering of Complex Musculoskeletal Tissues and JointsDP1AR068147 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2014 to 2018
$4.1M
A Translational Approach Towards Ligament RegenerationR01AR063698 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LAURENCIN, CATO T. · 2013 to 2018
$1.9M
NIAMS NIH HHS DP1 AR068147NIAMS NIH HHS R01 AR063698
6 · The paper itself

Abstract

Inflammation leads to chondrocyte senescence and cartilage degeneration, resulting in osteoarthritis (OA). Adipose-derived stem cells (ADSCs) exert paracrine effects protecting chondrocytes from degenerative changes. However, the lack of optimum delivery systems for ADSCs limits its use in the clinic. The use of extracellular matrix based injectable hydrogels has gained increased attention due to their unique properties. In the present study, we developed hydrogels from amnion tissue as a delivery system for ADSCs. We investigated the potential of amnion hydrogel to maintain ADSC functions, the synergistic effect of AM with ADSC in preventing the catabolic responses of inflammation in stimulated chondrocytes. We also investigated the role of Wnt/β-catenin signaling pathway in IL-1β induced inflammation in chondrocytes and the ability of AM-ADSC to inhibit Wnt/β-catenin signaling. Our results showed that AM hydrogels supported cell viability, proliferation, and stemness. ADSCs, AM hydrogels and AM-ADSCs inhibited the catabolic responses of IL-1β and inhibited the Wnt/β-catenin signaling pathway, indicating possible involvement of Wnt/β-catenin signaling pathways in IL-1β induced inflammation. The results also showed that the synergistic effect of AM-ADSCs was more pronounced in preventing catabolic responses in activated chondrocytes. In conclusion, we showed that AM hydrogels can be used as a potential carrier for ADSCs, and can be developed as a potential therapeutic agent for treating OA.

Indexed as

AdipocytesAmnionAnimalsCell ProliferationCells, CulturedChondrocytesCytokinesFemaleHumansHydrogelsInflammationInterleukin-1betaMesenchymal Stem CellsNitric OxideRatsStem CellsCytokinesHydrogelsInterleukin-1betaNitric Oxide

Identifiers

PMID33127964
PMCPMC7603317
OpenAlexW3094871533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.